Erectile dysfunction and lower urinary tract symptoms: A consensus on the importance of co-diagnosis

International Journal of Clinical Practice

Volumn 67, Issue 7, 2013, Pages 606-618

  Kirby, M ^a,b   Chapple, C ^c   Jackson, G ^d   Eardley, I ^e   Edwards, D ^f   Hackett, G ^g   Ralph, D ^h   Rees, J ⁱ   Speakman, M ^j   Spinks, J ^k   Wylie, K ^l  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b Prostate Centre   (United Kingdom)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^d Guys Kings and St Thomas Dental Institute   (United Kingdom)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f Horsefair   (United Kingdom)

^g UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^h St Peter's Andrology Centre   (United Kingdom)

ⁱ Backwell and Nailsea Medical Group   (United Kingdom)

^j TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^k Court View Surgery ^*  (United Kingdom)

^l ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC GMP; DOXAZOSIN; DUTASTERIDE; FINASTERIDE; PLACEBO; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SILODOSIN; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

ADVERSE OUTCOME; AGE; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOGONADISM; INSOMNIA; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE DISEASE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION; SMOKING; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CONSENSUS; ERECTILE DYSFUNCTION; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROSTATIC HYPERPLASIA; REFERRAL AND CONSULTATION; RISK FACTORS; UROLOGICAL AGENTS;

EID: 84879089647     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12176     Document Type: Article

References (89)

1. Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010; 57: 804-14.
2. Prins J, Blanker MH, Bohnen AM, et al. Prevalence of erectile dysfunction: a systematic review of population-based studies. Int J Impot Res 2002; 14: 422-32.
3. Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000; 12: 305-11.
4. Boyle P, Robertson C, Mazzetta C, et al. The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. BJU Int 2003; 92: 719-25.
5. Inman BA, St Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108-13.
6. NICE clinical guideline 97. Lower urinary tract symptoms. The management of lower urinary tract symptoms in men. http://www.nice.org.uk/guidance/CG97/ FullGuidance (accessed May 2010).
7. Glasser DB, Carson C III, Kang JH, Laumann EO,. Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study. Int J Clin Pract 2007; 61: 1294-300.
8. Sexton CC, Coyne KS, Kopp ZS, et al. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden. EpiLUTS BJU Int 2009; 103 (Suppl. 3): 12-23.
9. Roosen A, Chapple CR, Dmochowski RR, et al. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol 2009; 56: 810-9.
10. Parsons JK,. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep 2010; 5: 212-8.
11. Verhamme KM, Dieleman JP, Bleumink GS, et al. Pan European Expert Panel. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care-the triumph project. Eur Urol 2002; 42: 323.
12. Wei JT, Calhoun E, Jacobsen SJ,. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005; 173: 1256-61.
13. Kupelian V, Wei JT, O'Leary MP, et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) survey. Arch Intern Med 2006; 166: 2381-7.
14. Taylor BC, Wilt TJ, Fink HA, et al. Prevalence, severity and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology 2006; 68: 804-9.
15. Parsons JK, Bergstrom J, Silberstein J, Barrett-Connor E,. Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years. Urology 2008; 72: 318-21.
16. van Moorselaar J,. LUTS and sexual dysfunction: implications for management of BPH. Eur Urol Suppl 2003; 2: 13-20.
17. Sand MS, Fisher W, Rosen R, et al. Erectile dysfunction and constructs of masculinity and quality of life in the multinational men's attitudes to life events and sexuality (MALES) study. J Sex Med 2008; 5: 583-94.
18. Fisher WA, Rosen RC, Eardley I, et al. Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005; 2: 675-84.
19. Wein AJ, Coyne KS, Tubaro A, et al. The impact of lower urinary tract symptoms on male sexual health: EpiLUTS. BJU Int 2009; 103 (Suppl. 3): 33-41.
20. Mitropoulus D, Anastasiou I, Giannopouluo C, et al. Symptomatic benign prostate hyperplasia: impact on partners' quality of life. Eur Urol 2002; 41: 240-5.
21. Sells H, Donovan J, Ewings P, MacDonagh RP,. The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic hyperplasia. BJU Int 2000; 85: 440-5.
22. Seftel AD, Rosen RC, Rosenberg MT, Sadovsky R,. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty. Int J Clin Pract 2008; 62: 614-22.
23. Chitale S, Collins R, Hull S, Smith E, Irving S,. Is the current practice providing an integrated approach to the management of LUTS and ED in primary care? An audit and literature review. J Sex Med 2007; 4: 1713-25.
24. Map of Medicine 2012. http://www.mapofmedicine.com (accessed 20 April 2012).
25. Merrill JM, Laux LF, Thornby JI,. Why doctors have difficulty with sex histories. South Med J 1990; 83: 613-7.
26. Seftel AD, de la Rosette J, Birt J, et al. Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data. Int J Clin Pract 2013; 67: 32-45.
27. Gacci M, Eardley I, Giuliano F, et al. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2011; 60: 809-25.
28. McVary KT,. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 2005; 47: 838-45.
29. Kohler TS, McVary KT,. The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors. Eur Urol 2009; 55: 38-48.
30. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 637-49.
31. Morant S, Bloomfield G, Vats V, Chapple C,. Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms. J Sex Med 2009; 6: 1103-10.
32. Shiri R, Häkkinen J, Koskimäki J, et al. Erectile dysfunction influences the subsequent incidence of lower urinary tract symptoms and bother. Int J Impot Res 2007; 19: 317-20.
33. Andersson KE, de Groat WC, McVary KT, et al. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn 2011; 30: 292-301.
34. Penna G, Fibbi B, Amuchastegui S, et al. Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation. J Immunol 2009; 182: 4056-64.
35. Corona G, Maggi M,. The role of testosterone in erectile dysfunction. Nat Rev Urol 2010; 7: 46-56.
36. Jackson G, Boon N, Eardley I, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract 2010; 64: 848-57.
37. Lightner DJ, Krambeck AE, Jacobson DJ, et al. Nocturia is associated with an increased risk of coronary heart disease and death. BJU Int 2012; 110: 848-53.
38. Kupelian V, Araujo AB, Gretchen R, et al. Relative contributions of modifiable risk factors to erectile dysfunction. Results from the Boston Area Community Health (BACH) Survey. Prev Med 2010; 50: 19.
39. Feldman HA, I Goldstein, DG Hatzichristou, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
40. Hyde Z, Flicker L, Hankey GJ, et al. Prevalence and predictors of sexual problems in men aged 75-95 years: a population-based study. J Sex Med 2012; 9: 442-53.
41. Nehra A, Jackson G, Miner M, et al. The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2012; 87: 766-78.
42. Miner M, Seftel AD, Nehra A, et al. Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J 2012; 164: 21-8.
43. Favilla V, Cimino S, Castelli T, et al. Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia. BJU Int 2010; 106: 1700-3.
44. Lee S.H, Lee W.K., Lee S.K, et al. The association between lower urinary tract symptoms and depression in aging men: Hallym Aging Study. Eur Urol Suppl 2011; 10: 30.
45. Lee RK, Chung D, Chughtai B, et al. Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms. BJU Int 2012; 110: 540-5.
46. St Sauver JL, Jacobsen SJ, Jacobson DJ, et al. Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms. BJU Int 2011; 107: 443-50.
47. Hammarsten J, Peeker R,. Urological aspects of the metabolic syndrome. Nat Rev Urol 2011; 8: 483-94.
48. Kassi E, Pervanidou P, Kaltsas G, Chrousos G,. Metabolic syndrome: definitions and controversies. BMC Med 2011; 9: 48.
49. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity: harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
50. Mirone M, Sessa A, Giuliano F, et al. Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events. Int J Clin Pract 2011; 65: 1005-13.
51. Rosen RC, Link CL, O'Leary MP, et al. Lower urinary tract symptoms and sexual health: the role of gender, lifestyle and medical co-morbidities. BJU Int 2009; 103 (Suppl. 3): 42-7.
52. Chapple CR, Montorsi F, Tammela TLJ, et al. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol 2011; 59: 342-52.
53. McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387-98.
54. Ferrario CM, Levy P,. Sexual dysfunction in patients with hypertension: implications for therapy. J Clin Hypertens 2002; 4: 424-32.
55. Baldwin D, Mayers A,. Antipsychotics and antidepressants sexual side-effects of antidepressant and antipsychotic drugs. Adv Psychiatr Treat 2003; 9: 202-10.
56. WebMD Erectile Dysfunction Health Centre 2012. http://www.webmd.com/ erectile-dysfunction/guide/drugs-linked-erectile-dysfunction (accessed 20 April 2012).
57. Parsons JK, Messer K, White M, et al. Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men Study. Eur Urol 2011; 60: 1173-80.
58. Parsons JK,. Lifestyle factors, benign prostatic hyperplasia and lower urinary tract symptoms. Curr Opin Urol 2011; 21: 1-4.
59. Hackett G, Kell P, Ralph D, et al. British Society for Sexual Medicine guidelines on the management of erectile dysfunction. J Sex Med 2008; 5: 1841-65.
60. Oelke M, Burger M, Castro-Diaz D, et al. Diagnosis and medical treatment of lower urinary tract symptoms in adult men: applying specialist guidelines in clinical practice. BJU Int 2011; 110: 710-8.
61. Gujral S, Abrams P, Donovan JL, et al. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: the CLasP study. J Urol 2000; 164: 59-64.
62. McVary K, Foley KA, Long SR, et al. Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction. Curr Med Res Opin 2008; 24: 775-84.
63. Rosen RC, Wei JT, Althof SE, et al. BPH Registry and Patient Survey Steering Committee. Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry. Urology 2009; 73: 562-6.
64. Blanker MH, Bohnen AM, Groeneveld FPMJ, et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 2001; 49: 436-42.
65. Hansen BL,. Lower urinary tract symptoms (LUTS) and sexual function in both sexes. Eur Urol 2004; 46: 229-34.
66. Ponholzer A, Temml C, Obermayr R, Madersbacher S,. Association between lower urinary tract symptoms and erectile dysfunction. Urology 2004; 64: 772-6.
67. Chung WS, Nehra A, Jacobson DJ, et al. Lower urinary tract symptoms and sexual dysfunction in community-dwelling men. Mayo Clin Proc 2004; 79: 745-9.
68. Macfarlane GJ, Botto H, Sagnier PP, et al. The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol 1996; 49: 1171-6.
69. Frankel SJ, Donovan JL, Peters TI, et al. Sexual function in men with lower urinary tract symptoms. J Clin Epidemiol 1998; 51: 677-85.
70. Song J, Shao Q, Tian Y, et al. Association between lower urinary tract symptoms and erectile dysfunction in males aged 50 years and above: results from a multicenter community-based cross-sectional survey (BPC-BPH). Zhonghua Yi Xue Za Zhi 2011; 91: 2706-9.
71. Vallancien G, Emberton M, Harving N, van Moorselaar J, for the ALFONE Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol 2003; 169: 2257-61.
72. Li MK, Garcia LA, Rosen R,. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of aging men from five Asian countries. BJU Int 2005; 96: 1339-54.
73. Ströberg P, Boman H, Gellerstedt M, Hedelin H,. Relationships between lower urinary tract symptoms, the bother they induce and erectile dysfunction. Scand J Urol Nephrol 2006; 40: 307-12.
74. Moreira ED Jr, Lisboa Lobo CF, Villa M, Nicolosi A, Glasser DB,. Prevalence and correlates of erectile dysfunction in Salvador, northeastern Brazil: a population-based study. Int J Impot Res 2002; 14 (Suppl. 2): S3-9.
75. El-Sakka AI,. Lower urinary tract symptoms in patients with erectile dysfunction: analysis of risk factors. J Sex Med 2006; 3: 144-9.
76. Ozayar A, Zumrutbas AE, Yaman O,. The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH. Int Urol Nephrol 2008; 40: 933-9.
77. Tsao CW, Cha TL, Lee SS, et al. Association between lower urinary tract symptoms and sexual dysfunction in Taiwanese men. Andrologia 2008; 40: 387-91.
78. Mehraban D, Naderi GH, Yahyazadeh SR, Amirchaghmaghi M,. Sexual dysfunction in aging men with lower urinary tract symptoms. Urol J 2008; 5: 260-4.
79. Wong SY, Chan D, Hong A, et al. Depression and lower urinary tract symptoms: two important correlates of erectile dysfunction in middle-aged men in Hong Kong. China Int J Urol 2006; 13: 1304-10.
80. Tsai CC, Liu CC, Huang SP, et al. The impact of irritative lower urinary tract symptoms on erectile dysfunction in aging Taiwanese males. Aging Male 2010; 13: 179-83.
81. Wang Y, Sun GF, He LJ, et al. Correlation of lower urinary tract symptoms with erectile dysfunction in men aged 50 years and above. Zhonghua Nan Ke Xue 2008; 14: 517-20.
82. Nakamura M, Fujimura T, Nagata M,. Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International index of erectile function-5 questionnaires. Aging Male 2012; 15: 111-4.
83. Rhoden EL, Riedner CE, Fornari A, et al. Evaluation of the association between lower urinary tract symptoms and erectile dysfunction, considering its multiple risk factors. J Sex Med 2008; 5: 2662-8.
84. Demir O, Akgul K, Akar Z, et al. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome. Aging Male 2009; 12: 29-34.
85. Elliott SP, Gulati M, Pasta DJ, et al. Obstructive lower urinary tract symptoms correlate with erectile dysfunction. Urology 2004; 63: 1148-52.
86. Ikuerowo SO, Akindiji YO, Akinoso OA, et al. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men. Urol Int 2008; 80: 296-9.
87. Glina S, Santana AW, Azank F, et al. Lower urinary tract symptoms and erectile dysfunction are highly prevalent in ageing men. BJU Int 2006; 97: 763-5.
88. Sugaya K, Kadekawa K, Ikehara A, et al. Influence of hypertension on lower urinary tract symptoms in benign prostatic hyperplasia. Int J Urol 2003; 10: 569-74.
89. Hwang TI, Lin YC,. The relationship between hypogonadism and erectile dysfunction. Int J Impot Res 2008; 20: 231-5.